AE Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.55M | Buy |
17,859
+3,550
| +25% | +$340K | 0.01% | 720 |
|
|
2025
Q4 | $1.37M | Buy |
14,309
+1,565
| +12% | +$152K | 0.01% | 716 |
|
|
2025
Q3 | $1.21M | Buy |
12,744
+2,324
| +22% | +$214K | 0.01% | 703 |
|
|
2025
Q2 | $908K | Buy |
10,420
+1,521
| +17% | +$129K | 0.01% | 752 |
|
|
2025
Q1 | $800K | Buy |
8,899
+597
| +7% | +$53.4K | 0.01% | 773 |
|
|
2024
Q4 | $663K | Sell |
8,302
-28
| -0.3% | -$2.42K | 0.01% | 818 |
|
|
2024
Q3 | $750K | Sell |
8,330
-1,248
| -13% | -$105K | 0.01% | 774 |
|
|
2024
Q2 | $754K | Buy |
9,578
+1,896
| +25% | +$155K | 0.01% | 781 |
|
|
2024
Q1 | $669K | Sell |
7,682
-133,825
| -95% | -$11.4M | 0.01% | 752 |
|
|
2023
Q4 | $12.2M | Buy |
141,507
+49,971
| +55% | +$3.81M | 0.06% | 350 |
|
|
2023
Q3 | $7.17M | Sell |
91,536
-10,995
| -11% | -$920K | 0.04% | 450 |
|
|
2023
Q2 | $9.03M | Sell |
102,531
-3,050
| -3% | -$263K | 0.05% | 388 |
|
|
2023
Q1 | $8.51M | Buy |
105,581
+27,308
| +35% | +$2.23M | 0.05% | 376 |
|
|
2022
Q4 | $6.08M | Buy |
78,273
+20,066
| +34% | +$1.63M | 0.04% | 427 |
|
|
2022
Q3 | $4.7M | Buy |
58,207
+10,467
| +22% | +$941K | 0.04% | 442 |
|
|
2022
Q2 | $4.29M | Buy |
47,740
+1,777
| +4% | +$180K | 0.03% | 433 |
|
|
2022
Q1 | $5.1M | Sell |
45,963
-3,747
| -8% | -$396K | 0.04% | 432 |
|
|
2021
Q4 | $5.14M | Buy |
49,710
+3,663
| +8% | +$424K | 0.04% | 406 |
|
|
2021
Q3 | $5.77M | Buy |
46,047
+3,752
| +9% | +$486K | 0.05% | 347 |
|
|
2021
Q2 | $5.25M | Buy |
42,295
+5,675
| +15% | +$713K | 0.05% | 353 |
|
|
2021
Q1 | $4.33M | Buy |
36,620
+3,922
| +12% | +$460K | 0.04% | 352 |
|
|
2020
Q4 | $3.83M | Buy |
32,698
+2,356
| +8% | +$259K | 0.04% | 326 |
|
|
2020
Q3 | $3.15M | Sell |
30,342
-2,689
| -8% | -$270K | 0.05% | 320 |
|
|
2020
Q2 | $3.03M | Sell |
33,031
-18,502
| -36% | -$1.77M | 0.05% | 306 |
|
|
2020
Q1 | $4.65M | Buy |
51,533
+2,813
| +6% | +$299K | 0.11% | 176 |
|
|
2019
Q4 | $5.53M | Buy |
48,720
+10,940
| +29% | +$1.2M | 0.12% | 164 |
|
|
2019
Q3 | $4.1M | Buy |
37,780
+24,703
| +189% | +$2.58M | 0.12% | 167 |
|
|
2019
Q2 | $1.27M | Buy |
13,077
+8,932
| +215% | +$816K | 0.04% | 339 |
|
|
2019
Q1 | $378K | Buy |
4,145
+367
| +10% | +$32.8K | 0.03% | 406 |
|
|
2018
Q4 | $344K | Sell |
3,778
-837
| -18% | -$78.2K | 0.06% | 321 |
|
|
2018
Q3 | $454K | Sell |
4,615
-550
| -11% | -$50.8K | 0.03% | 345 |
|
|
2018
Q2 | $442K | Buy |
5,165
+1,439
| +39% | +$120K | 0.03% | 276 |
|
|
2018
Q1 | $299K | Sell |
3,726
-411
| -10% | -$33.9K | 0.02% | 327 |
|
|
2017
Q4 | $334K | Buy |
4,137
+390
| +10% | +$31.2K | 0.03% | 296 |
|
|
2017
Q3 | $291K | Buy |
3,747
+511
| +16% | +$42.4K | 0.03% | 319 |
|
|
2017
Q2 | $287K | Sell |
3,236
-897
| -22% | -$75.6K | 0.03% | 303 |
|
|
2017
Q1 | $333K | Buy |
+4,133
| New | +$323K | 0.06% | 203 |
|
Other funds holding MDT
VCM
VPM
AE Wealth Management's MDT Position: Q1 2026 in Review
AE Wealth Management increased its Medtronic (MDT) stake by 25% in Q1 2026, buying an estimated $340K and bringing the position to 17,859 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #720.
AE Wealth Management first reported a position in MDT in Q1 2017 and has held it in 37 quarters since. The position peaked at $12.2M in Q4 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- AE Wealth Management held 17,859 shares of Medtronic worth $1.55M as of Q1 2026.
- AE Wealth Management bought 3,550 Medtronic shares in Q1 2026, an estimated $340K.
- Medtronic made up 0.01% of AE Wealth Management's portfolio in Q1 2026, its #720 holding.
- AE Wealth Management first reported a position in Medtronic in Q1 2017 and has held it in 37 quarters since.
- AE Wealth Management's Medtronic position peaked at $12.2M in Q4 2023.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.